Literature DB >> 22903548

Diagnostic and prognostic significance of serum microRNAs in colorectal cancer.

Pablo Menéndez1, Pedro Villarejo, David Padilla, José M Menéndez, Jose A Rodríguez Montes.   

Abstract

MicroRNAs are short non-coding RNA molecules involved in the regulation of gene expression. There are few studies related to the determination of serum microRNAs in colorectal cancer. The identification of microRNAs in peripheral blood as noninvasive markers of tumor disease may lead to potential applications, although further clinical studies focusing on serum microRNAs are required to determine their clinical significance for the diagnosis and prognosis outcome of colorectal cancer.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22903548     DOI： 10.1002/jso.23245

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


  9 in total

Review 1.  MicroRNAs in colorectal cancer as markers and targets: Recent advances.

Authors:  Jing-Jia Ye; Jiang Cao
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

Review 2.  Noninvasive micromarkers.

Authors:  Janani Saikumar; Krithika Ramachandran; Vishal S Vaidya
Journal:  Clin Chem       Date:  2014-01-09       Impact factor: 8.327

3.  A two-gene blood test for methylated DNA sensitive for colorectal cancer.

Authors:  Susanne K Pedersen; Rohan T Baker; Aidan McEvoy; David H Murray; Melissa Thomas; Peter L Molloy; Sue Mitchell; Trevor Lockett; Graeme P Young; Lawrence C LaPointe
Journal:  PLoS One       Date:  2015-04-30       Impact factor: 3.240

4.  Dynamic monitoring of circulating microRNAs as a predictive biomarker for the diagnosis and recurrence of papillary thyroid carcinoma.

Authors:  Yanqing Zhang; Desheng Xu; Jiaqi Pan; Zhengkai Yang; Meijun Chen; Jun Han; Sijia Zhang; Lulu Sun; Hong Qiao
Journal:  Oncol Lett       Date:  2017-04-11       Impact factor: 2.967

Review 5.  The Management of Cardiovascular Risk through Epigenetic Biomarkers.

Authors:  Laurent Metzinger; Stefano de Franciscis; Raffaele Serra
Journal:  Biomed Res Int       Date:  2017-07-13       Impact factor: 3.411

6.  Identification of serum microRNA profiles in colon cancer.

Authors:  E Hofsli; W Sjursen; W S Prestvik; J Johansen; M Rye; G Tranø; H H Wasmuth; I Hatlevoll; L Thommesen
Journal:  Br J Cancer       Date:  2013-04-04       Impact factor: 7.640

7.  Personalized medicine in screening for malignant disease: a review of methods and applications.

Authors:  F Schmalfuss; P L Kolominsky-Rabas
Journal:  Biomark Insights       Date:  2013-02-18

8.  microRNA-449a functions as a tumor-suppressor in gastric adenocarcinoma by targeting Bcl-2.

Authors:  Bin Wei; Ying Song; Yonghong Zhang; Mingjun Hu
Journal:  Oncol Lett       Date:  2013-10-09       Impact factor: 2.967

Review 9.  The Discovery of Novel Genomic, Transcriptomic, and Proteomic Biomarkers in Cardiovascular and Peripheral Vascular Disease: The State of the Art.

Authors:  Stefano de Franciscis; Laurent Metzinger; Raffaele Serra
Journal:  Biomed Res Int       Date:  2016-05-19       Impact factor: 3.411
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.